Purchase Order 36C25624P0605
Award Date
6/1/24
Potential Completion Date
5/31/29
Potential Value
$451K
Federal Agency
Veterans Integrated Service Network 16
Awardee
Veracyte, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Shreveport, LA 71101, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services, to conduct referral laboratory testing for thyroid genomic expression classifier (GEC) testing. The $202,552.00 contract has a period of performance through September 30, 2024. Veracyte has provided similar genomic testing services to support cancer detection and diagnosis for...
This firm fixed-price purchase order was awarded by the Veterans Health Administration's Veterans Integrated Service Network 17 (VISN 17) to Veracyte, Inc., a for-profit corporation that provides genomic testing services. The $512,000.00 contract will support cancer detection and diagnosis efforts for VISN 17 facilities through August 2027. Veracyte will provide genomic classifier laboratory testing to analyze gene expression patterns in biopsy samples, aiding in the diagnosis and treatment of...
This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 16 (VISN 16), part of the U.S. Department of Veterans Affairs, to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for thyroid testing services, with a ceiling value of $165,200.00 and a period of performance through April 30, 2026. Veracyte has provided similar laboratory testing services to the Department of Defense and Veterans Affairs in the past, using...
This is a firm fixed price, definitive contract awarded by the Veterans Integrated Service Network 16 of the U.S. Department of Veterans Affairs to Veracyte, Inc. for laboratory sample testing services. The contract has a ceiling value of $342,256.60 and a period of performance through December 31, 2025. Veracyte, Inc., a for-profit corporation, will provide genomic testing services to support cancer detection and diagnosis efforts, as well as differentiation of idiopathic pulmonary fibrosis, at...
This is a $141,132.01 firm fixed price contract awarded by the Veterans Health Administration's Veterans Integrated Service Network 8 (VISN 8) to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for cancer screening tests, with no set-aside designation. Veracyte has also been awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle from VISN 23 to provide reference laboratory services, with a potential value of $600,000 through April 2028....
This is a $84,000.00 firm fixed-price Delivery Order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23 to Veracyte, Inc., a for-profit corporate entity specializing in advanced genomic testing services for medical diagnostics. The contract provides reference laboratory services for VISN 23. This award is not set-aside for any specific business category. Veracyte holds several significant Indefinite Delivery Vehicle (IDV) contracts with the VA and...
This firm fixed-price federal contract, awarded by the Department of Veterans Affairs to Veracyte, Inc., provides specialty genomic laboratory testing services to support cancer detection and diagnosis efforts at VA medical facilities. The contract has a ceiling value of $353,303.84 and a performance period through July 15, 2026. Veracyte, a for-profit organization, will perform the work at its commercial laboratories. The contract is not set aside and is awarded under Veracyte's existing...
This firm fixed price federal contract award was made by the Defense Health Agency (DHA) to Veracyte, Inc., a for-profit corporate entity that provides genomic testing services. The contract is for $116,000.00 and has a period of performance ending on September 30, 2015. The services provided under this contract include analyzing gene expression patterns in biopsy samples to determine malignancy risk, aid in diagnosis and treatment decisions, as well as testing to differentiate idiopathic...
This is a firm fixed price purchase order contract awarded by the U.S. Army Medical Command to Veracyte, Inc., a for-profit organization that provides genomic testing services. The contract, valued at $96,176.63, is for the provision of supply/service in support of the agency's cancer detection and diagnosis efforts. Veracyte holds an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle with the Veterans Health Administration's Veterans Integrated Service Network 23, valued at up to...
This is a delivery order contract awarded by the Department of Veterans Affairs' VISN 23 to Veracyte, Inc., a for-profit medical diagnostic company. The $25,400.00 firm fixed-price contract is for Veracyte to provide reference laboratory services, including specialized genomic testing and classifier services, to support the VA's healthcare delivery to veterans. The contract is not set aside for any specific business category. Veracyte has been awarded several Indefinite Delivery Vehicle (IDV)...